Equitape Wormer Syringe (single syringe)

In is important to use any wormer as part of a tailored worming plan, to minimise the development of resistant worms. If you need advice in putting into action a plan for your horses, please contact us, or speak to your vet.
A white paste containing: 90.0mg/g praziquantel Ph.Eur as active substance and 0.2mg/g propyl parahydroxybenzoate (E216) and 1.4mg/g methyl parahydroxybenzoate (E218) as preservatives.
Praziquantel is a pyrazino-isoquinoline derivative. For the single dose treatment of infections with cestodes (tapeworms) of the species Anoplocephala perfoliata sensitive to praziquantel.
Visit www.myvetmeds.co.uk / equine / wormers-equine / equitape-wormer-syringe.htm
Product Description
About Equitape Wormer Syringe (single syringe)
In is important to use any wormer as part of a tailored worming plan, to minimise the development of resistant worms. If you need advice in putting into action a plan for your horses, please contact us, or speak to your vet.
A white paste containing: 90.0mg/g praziquantel Ph.Eur as active substance and 0.2mg/g propyl parahydroxybenzoate (E216) and 1.4mg/g methyl parahydroxybenzoate (E218) as preservatives.
Praziquantel is a pyrazino-isoquinoline derivative. For the single dose treatment of infections with cestodes (tapeworms) of the species Anoplocephala perfoliata sensitive to praziquantel.
Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.
Directions For Use
Directions for Use
For oral administration. One 6.67g syringe contains sufficient paste to treat one 600kg horse at the recommended dose rate (1mg praziquantel per kg bodyweight). Each graduation on the calibrated syringe delivers sufficient paste to treat 50kg bodyweight. Use of a scale or weigh tape is recommended to ensure accurate dosing.
Active Ingredient
Equitape Wormer Syringe (single syringe) ingredients
A white paste containing: 90.0mg/g praziquantel Ph.Eur as active substance and 0.2mg/g propyl parahydroxybenzoate (E216) and 1.4mg/g methyl parahydroxybenzoate (E218) as preservatives.
Side Effects
Side effects of Equitape Wormer Syringe (single syringe)
Do not use in horses producing milk for human consumption.
Withdrawal period for edible tissue: zero days
The safety of EQUITAPE has not been studied following administration to mares during gestation and lactation, and as such should only be used in mares during pregnancy and lactation after assessment of the benefit/risk balance by your veterinary surgeon.
Wash hands thoroughly after treating animals.
Do not eat, drink or smoke during application.
Any spillage of the product onto human skin should be removed by washing with soap and water.
Read entire package insert before use.
For animal treatment only.
Keep out of reach of children.
Environmental Safety
In order to limit pasture excretion of the product and its metabolites, horses should remain stabled for 2 days after treatment. Unused product or waste material must be disposed of in accordance with national waste disposal requirements.
Additional Data
Equitape Wormer Syringe (single syringe) specification
| Specification: | Detail: |
|---|---|
| Associated Documents: |
Click here to preview |
| Pack Size: | single syringe |
| Brands: | Fort Dodge |
| Product Form: | paste |
| External Link: | http://www.noahcompendium.co.uk/Pfizer_Limited/documents/S3940.html |

















